News

February 6, 2018February 6, 2018

Single Blood Test Screens for 8 Cancer Types, Helps Spot Tumor Location

Lung Cancer, News

A new blood test can screen for eight cancer types and help spot the tumor location, a recent study from Johns Hopkins Kimmel Cancer Center shows. The research, “Detection and localization ... Read more

February 2, 2018February 2, 2018

FDA Approves Phase 3 Trial Plan for Prometic’s Pulmonary Fibrosis Therapy

Idiopathic Pulmonary Fibrosis, News

The U.S. Food and Drug Administration has approved Prometic Life Sciences’ plan for a Phase 3 pivotal trial of its idiopathic pulmonary fibrosis therapy PBI-4050. PBI-4050 is an oral compound designed to ... Read more

February 1, 2018February 1, 2018

FDA Gives Aradigm Recommendations for Resubmitting Bronchiectasis Therapy Application

Bronchiectasis, News

The U.S. Food and Drug Administration has given Aradigm a list of suggestions for resubmitting an application for regulatory review of its bronchiectasis therapy Linhaliq. A review board had recommended against the FDA ... Read more

January 31, 2018January 31, 2018

Singing for Lung Health Kicks Off in Bristol, UK

Idiopathic Pulmonary Fibrosis, News

Bristol is the most recent U.K. city hosting a Singing for Breathing group, called Singing for Lung Health, an initiative created to help anyone living with a lung condition as ... Read more

January 30, 2018January 30, 2018

FibroKine Inhaled Aerosol Delivery System for PF Awarded Early-stage Development Grant

Idiopathic Pulmonary Fibrosis, News

The University of Pittsburgh’s Center for Medical Innovation (CMI) awarded a total of $115,000 to advance the development of five proposed solutions to medical conditions. One of the recipients is ... Read more

January 29, 2018January 29, 2018

COPD Care at Home Rather Than Hospital Boosts Patient Outcomes, Canadian Study Finds

COPD, News

Moving chronic obstructive pulmonary disease (COPD) patients from hospitals to their homes could improve the sustainability of Canada’s health system while improving individual outcomes, says the Canadian Foundation for Healthcare Improvement ... Read more

January 26, 2018January 26, 2018

Three Winners Will Share $1 Million for Innovation in IPF Catalyst Challenge

Idiopathic Pulmonary Fibrosis, News

Three companies will equally share $1 million for winning the IPF Catalyst Challenge, a competition that fosters innovative solutions for helping idiopathic pulmonary fibrosis (IPF) patients. The winners are Advanced Interactive Response Systems ... Read more

January 25, 2018January 25, 2018

CDC Studies Asthma Burden on U.S. Economy — and Numbers are Striking

Asthma, News

Asthma costs the U.S. economy nearly $82 billion a year, say researchers at the Centers for Disease Control and Prevention (CDC). Using data from the Medical Expenditure Panel Survey, one of ... Read more

January 24, 2018January 24, 2018

Finalists for $1 million IPF Catalyst Challenge Includes patientMpower

Idiopathic Pulmonary Fibrosis, News

PatientMpower is one of the selected finalists of the IPF Catalyst Challenge to receive $1 million to fund research into idiopathic pulmonary fibrosis (IPF). The IPF Catalyst Challenge, being held ... Read more

January 23, 2018January 23, 2018

Interstitial Lung Disease Diagnoses Usually Inaccurate, Emotionally Trying, Patient Survey Shows

Idiopathic Pulmonary Fibrosis, News

A nationwide patient survey highlights the lengthy and often inaccurate diagnosis of interstitial lung disease (ILD), as well as the emotional stress it causes in patients. The research, “Barriers to ... Read more